Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study Comparing Symbicort® 'as Needed' With Terbutaline 'as Needed' and With Pulmicort® Twice Daily Plus Terbutaline 'as Needed' in Adult and Adolescent Patients With Asthma.

NCT02149199 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02149199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02149199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study Comparing Symbicort® 'as Needed' With Terbutaline 'as Needed' and With Pulmicort® Twice Daily Plus Terbutaline 'as Needed' in Adult and Adolescent Patients With Asthma.
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
July 7, 2014
Completion date
August 2, 2017
Enrollment
3,850 (actual)
Sites
255

Conditions

As the registry lists them; a condition with its own page is linked.

asthma